Gabor Mikala Selected Research

Gabor Mikala Research Topics

13	Multiple Myeloma 02/2024 - 06/2011
2	Neoplasms (Cancer) 02/2024 - 03/2009
2	Lymphoma (Lymphomas) 11/2012 - 07/2011
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2012 - 07/2011
1	Neutropenia 10/2023
1	Sepsis (Septicemia) 10/2023
1	Thrombocytopenia (Thrombopenia) 10/2023
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 08/2023
1	Plasmacytoma 11/2022
1	COVID-19 12/2021
1	Pain (Aches) 07/2009
1	Sleep Wake Disorders 07/2009
1	Epilepsy (Aura) 07/2009
1	Carcinogenesis 03/2009

4	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 11/2022
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 06/2011
3	isatuximabIBA 12/2022 - 11/2022
3	carfilzomibIBA 12/2022 - 11/2022
3	plerixafor FDA Link 11/2012 - 06/2011
2	Lenalidomide (CC 5013)FDA Link 10/2023 - 02/2012
2	pomalidomideIBA 10/2023 - 11/2022
1	Polyvinyl Chloride (PVC)IBA 02/2024
1	melflufenIBA 02/2024
1	Peptides (Polypeptides)IBA 02/2024
1	Melphalan (Alkeran)FDA LinkGeneric 02/2024
1	belantamab mafodotinIBA 10/2023
1	Proteasome InhibitorsIBA 10/2023
1	zilucoplanIBA 08/2023
1	Monoclonal AntibodiesIBA 12/2022
1	Methylprednisolone FDA LinkGeneric 12/2021
1	baricitinibIBA 12/2021
1	Thalidomide (Thalomid)FDA Link 12/2021
1	tocilizumab (atlizumab)FDA Link 12/2021
1	Bortezomib (Velcade)FDA Link 01/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2018
1	fludarabineIBA 02/2012
1	Essential DrugsIBA 02/2012
1	Gabapentin (Neurontin)FDA LinkGeneric 07/2009
1	IronIBA 03/2009
1	Proteins (Proteins, Gene)FDA Link 03/2009

2	Therapeutics 10/2023 - 12/2020
2	Hematopoietic Stem Cell Mobilization 11/2012 - 06/2011
1	Intravenous Administration 02/2024
1	Autologous Transplantation 01/2023
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Drug Therapy (Chemotherapy) 07/2011
1	Stem Cell Transplantation 06/2011
1	Transplantation 06/2011